← Leaderboards
Amy Hauck Newman
National Institute On Drug Abuse
$5,286
Attributed
$5,286
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$5,286 · 1
By mechanism
P51$5,286 · 1
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocainePharmaceutical PreparationsLigandsIn VivoAnalogDopamineAffinityBaseReceptorStructureDesignRattusReportingSeriesStructure-Activity RelationshipBehavioralModificationAgonistCellsAddictionParentsDopamine TransporterNucleus AccumbensBrain
Grant awards (88)
Novel Dopamine D3/D2 Receptor Ligands$976,135
ZIA · FY2025 · DA · contact PI
Novel Probes for the Monoamine Transporters$976,135
ZIA · FY2025 · DA · contact PI
Novel Dopamine D3/D2 Receptor Ligands$1,660,663
ZIA · FY2024 · DA · contact PI
Novel Probes for the Monoamine Transporters$1,660,663
ZIA · FY2024 · DA · contact PI
Novel Dopamine D3/D2 Receptor Ligands$11,662,952
ZIA · FY2023 · DA · contact PI
Novel Probes for the Monoamine Transporters$1,682,952
ZIA · FY2023 · DA · contact PI
Novel Dopamine D3/D2 Receptor Ligands$1,013,104
ZIA · FY2022 · DA · contact PI
Novel Probes for the Monoamine Transporters$1,013,104
ZIA · FY2022 · DA · contact PI
Novel Probes for the Monoamine Transporters$903,355
ZIA · FY2021 · DA · contact PI
Novel Dopamine D3/D2 Receptor Ligands$903,355
ZIA · FY2021 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$622,131
ZIA · FY2020 · DA · contact PI
Novel and Atypical Dopamine Uptake Inhibitors$518,442
ZIA · FY2020 · DA · contact PI
Dopamine D2-like Functionally Selective Agonists$518,442
ZIA · FY2020 · DA · contact PI
Monoamine Transporter Nanoprobes$414,753
ZIA · FY2020 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$725,509
ZIA · FY2019 · DA · contact PI
Dopamine D2-like Functionally Selective Agonists$580,407
ZIA · FY2019 · DA · contact PI
Novel and Atypical Dopamine Uptake Inhibitors$580,407
ZIA · FY2019 · DA · contact PI
Monoamine Transporter Nanoprobes$435,305
ZIA · FY2019 · DA · contact PI
Glutamate and Addiction$290,203
ZIA · FY2019 · DA · contact PI
Central CB1 and CB2 Cannabinoid Receptors$290,203
ZIA · FY2019 · DA · contact PI
Novel and Atypical Dopamine Uptake Inhibitors$572,799
ZIA · FY2018 · DA · contact PI
Monoamine Transporter Nanoprobes$572,799
ZIA · FY2018 · DA · contact PI
Dopamine D2-like Functionally Selective Agonists$572,799
ZIA · FY2018 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$572,799
ZIA · FY2018 · DA · contact PI
Glutamate and Addiction$286,400
ZIA · FY2018 · DA · contact PI
Central CB1 and CB2 Cannabinoid Receptors$286,400
ZIA · FY2018 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$566,377
ZIA · FY2017 · DA · contact PI
Dopamine D2-like Functionally Selective Agonists$566,377
ZIA · FY2017 · DA · contact PI
Novel and Atypical Dopamine Uptake Inhibitors$566,377
ZIA · FY2017 · DA · contact PI
Monoamine Transporter Nanoprobes$566,377
ZIA · FY2017 · DA · contact PI
Glutamate and Addiction$283,188
ZIA · FY2017 · DA · contact PI
Central CB2 Cannabinoid Receptors$283,188
ZIA · FY2017 · DA · contact PI
Novel and Atypical Dopamine Uptake Inhibitors$531,995
ZIA · FY2016 · DA · contact PI
Monoamine Transporter Nanaoprobes$531,995
ZIA · FY2016 · DA · contact PI
Dopamine D2-like Functionally Selective Agonists$531,995
ZIA · FY2016 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$531,995
ZIA · FY2016 · DA · contact PI
Endocannabinoid roles in neurochemical and reinforcing effects of abused drugs$1,696,004
ZIA · FY2015 · DA · contact PI
Novel Dopamine D2 and D3 Receptor Ligands$969,378
ZIA · FY2015 · DA · contact PI
Novel Probes For Monoamine Transporters$969,378
ZIA · FY2015 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$905,544
ZIA · FY2015 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$388,090
ZIA · FY2015 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$972,642
ZIA · FY2014 · DA · contact PI
Novel Probes For Monoamine Transporters$972,642
ZIA · FY2014 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$909,120
ZIA · FY2014 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$389,623
ZIA · FY2014 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$1,002,774
ZIA · FY2013 · DA · contact PI
Pharmacology and toxicology of newly-emerging designer drugs of abuse$609,062
ZIA · FY2013 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$609,062
ZIA · FY2013 · DA · contact PI
Novel Probes For Monoamine Transporters$601,665
ZIA · FY2013 · DA · contact PI
mGluR5 Allosteric Modulators$401,110
ZIA · FY2013 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$1,505,719
ZIA · FY2012 · DA · contact PI
Novel Probes For Monoamine Transporters$903,432
ZIA · FY2012 · DA · contact PI
mGluR5 Allosteric Modulators$602,288
ZIA · FY2012 · DA · contact PI
Pharmacological characterization of novel opioid drugs$540,011
ZIA · FY2012 · DA · contact PI
Medication development of agonist-type treatment agents for stimulant addiction$405,008
ZIA · FY2012 · DA · contact PI
Medication development of non-addicting opioid analgesics$270,006
ZIA · FY2012 · DA · contact PI
Mechanisms of serotonergic toxicity produced by MDMA and other agent$135,003
ZIA · FY2012 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$776,405
ZIA · FY2011 · DA · contact PI
mGluR5 Allosteric Modulators$582,304
ZIA · FY2011 · DA · contact PI
Novel Probes For Monoamine Transporters$582,304
ZIA · FY2011 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$688,571
ZIA · FY2010 · DA · contact PI
Novel Probes For Monoamine Transporters$688,571
ZIA · FY2010 · DA · contact PI
mGluR5 Allosteric Modulators$590,204
ZIA · FY2010 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$701,488
ZIA · FY2009 · DA · contact PI
Novel Probes For The Dopamine Transporter$701,488
ZIA · FY2009 · DA · contact PI
mGluR5 Allosteric Modulators$601,275
ZIA · FY2009 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$1,034,943
Z01 · FY2008 · DA · contact PI
mGluR5 Allosteric Modulators$517,472
Z01 · FY2008 · DA · contact PI
Novel Probes For The Dopamine Transporter$517,472
Z01 · FY2008 · DA · contact PI
mGluR5 Allosteric Modulators$805,173
Z01 · FY2007 · DA · contact PI
Novel Probes For The Dopamine Transporter$802,762
Z01 · FY2007 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$802,762
Z01 · FY2007 · DA · contact PI
D3 RECEPTOR LIGANDS AS TOOLS FOR IN VIVO INVESTIGATION IN MODELS OF DRUG ABUSE$5,286
P51 · FY2007 · RR · contact PI
Novel Probes For The Dopamine Transporter$0
Z01 · FY2006 · DA · contact PI
mGluR5 Allosteric Modulators$0
Z01 · FY2006 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2006 · DA · contact PI
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2005 · DA
Novel Probes For The Dopamine Transporter$0
Z01 · FY2005 · DA
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2004 · DA
Novel Probes For The Dopamine Transporter$0
Z01 · FY2004 · DA
Novel Probes For The Dopamine Transporter$0
Z01 · FY2003 · DA
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2003 · DA
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2002 · DA
Novel Probes For The Dopamine Transporter$0
Z01 · FY2002 · DA
Novel Dopamine D3 Receptor Ligands$0
Z01 · FY2001 · DA
Novel Probes For The Dopamine Transporter$0
Z01 · FY2001 · DA
NOVEL PROBES FOR THE DOPAMINE TRANSPORTER$0
Z01 · FY2000 · DA
NOVEL DOPAMINE D3 RECEPTOR LIGANDS$0
Z01 · FY2000 · DA